Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CGEN Compugen > Detailed Quotes

CGEN Compugen

0.690
+0.006+0.88%
Close 10/05 16:00 ET
0.700
+0.010+1.38%
Post Mkt Price 10/05 17:34 ET
High
0.710
Open
0.700
Turnover
595.46K
Low
0.620
Pre Close
0.684
Volume
898.28K
Market Cap
59.77M
P/E(TTM)
Loss
52wk High
7.480
Shares
86.62M
P/E(Static)
Loss
52wk Low
0.620
Float Cap
54.95M
Bid/Ask %
20.00%
Historical High
19.900
Shs Float
79.64M
Volume Ratio
1.14
Historical Low
0.340
Dividend TTM
--
Div Yield TTM
--
P/B
0.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.13%
Amplitude
13.12%
Avg Price
0.662
Lot Size
1
Float Cap
54.95M
Bid/Ask %
20.00%
Historical High
19.900
Shs Float
79.64M
Volume Ratio
1.14
Historical Low
0.340
Dividend TTM
--
P/B
0.66
Dividend LFY
--
Turnover Ratio
1.13%
Amplitude
13.12%
Avg Price
0.662
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
CEO: Dr. Anat Cohen-Dayag, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...